What is the Level of Evidence Substantiating Commercial Payers’ Coverage Policies for Total Joint Arthroplasty?

The prevalence of total joint arthroplasty (TJA) in the United States has drawn the attention of health care stakeholders. The payers have also used a variety of strategies to regulate the medical necessity of these procedures. The purpose of this study was to examine the level of evidence of the co...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	The Journal of arthroplasty 2021-08, Vol.36 (8), p.2665-2673.e8
Hauptverfasser:	Austin, Matthew S., Ashley, Blair S., Bedard, Nicholas A., Bezwada, Hari P., Hannon, Charles P., Fillingham, Yale A., Kolwadkar, Yogesh V., Rees, Harold W., Grosso, Matthew J., Zeegen, Erik N.
Format:	Artikel
Sprache:	eng
Schlagworte:	Arthroplasty, Replacement, Hip Arthroplasty, Replacement, Knee commercial payers health care policy Humans level of evidence Policy total joint arthroplasty treatment algorithm United States
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!